Featured Research

from universities, journals, and other organizations

To restore vision, implant preps and seeds a damaged eye

Date:
January 26, 2010
Source:
Case Western Reserve University
Summary:
A tiny eye implant that clears scar tissue and delivers progenitor cells designed to replace photoreceptors damaged by disease passes early tests.

Researchers trying to restore vision damaged by disease have found promise in a tiny implant that sows seeds of new cells in the eye.

Related Articles


The diseases macular degeneration and retinitis pigmentosa lay waste to photoreceptors, the cells in the retina that turn light into electrical signals carried to the brain. The damage leaves millions of people worldwide with debilitating sight loss.

The nerves behind the light-switching cells, however, remain intact, meaning that with new photoreceptors, a patient could see again.

Early attempts to regenerate sight by injecting seed or progenitor cells that grow into photoreceptors into the eye of a mouse model failed.

"As with any part of the central nervous system, scar tissue is a barrier to regeneration," said Gary Wnek, a professor of macromolecular science and engineering at Case Western Reserve University.

Wnek, the Joseph F. Toot, Jr. Professor of Engineering, and Meghan Smith, a recent Ph.D. recipient at CWRU, joined a team of researchers from Harvard University and the University of California, Irvine, to design an implant that clears scar tissue left by disease and delivers progenitor cells.

They report their results in the January issue of Biomaterials.

Wnek and Smith made the micro-implant's scaffolding. They built a mesh through a process called electrospinning, which uses electrical charges to draw biodegradable polymers out of a needle and into a fine stream, producing interwoven fibers ranging from 1/20th to 1/1000th the width of a hair, Smith explained.

Embedded in the fibers are pockets containing enzymes which slowly migrate out as the polymer degrades, eating away local scar tissue and exposing fertile ground for the progenitor cells carried on the implant's surface.

Without the enzymes, the implant alone increased the number of progenitor cells reaching the degraded site 16-fold and survival 9- fold over injection in a mouse model. The mesh provided structural support for the cells and chemical support with a coating of extracellular fluid, said Budd A. Tucker, a postdoctoral fellow at the Schepens Eye Research Institute at Harvard and the lead author of the paper.

With the enzymes on board, the number of progenitor cells that implanted and survived increased another 15- to 20-fold Tucker said.

"No one knows what the magic number of cells needed to regain sight is," Tucker said. "But I suspect this is a reasonable number."

Published work has shown that people who suffer sight loss can regain visual acuity with the addition of fewer photoreceptor cells than the number that naturally populate a healthy eye, he said.

In a mouse model that received the implant, progenitor cells were taking on the form of mature photoreceptors and expressed mature photoreceptor markers 14 days after implantation.

Erin Lavik, a professor of biomedical engineering at Case Western Reserve, worked on early implant models with the Harvard researchers but is no longer involved in the effort. She's impressed by the new mesh. "It's an elegant system that can clearly modify the environment," Lavik said.

The scientists are already improving the system, making the mesh about one-quarter to one-sixth as thick and using a more flexible polymer that is, well, easier on the eye, said Stephen Redenti, an assistant professor of biological sciences at City University of New York, and an author of this current and an upcoming paper on the implants.

"The implant made with the new polymer is almost as small as we can go and still handle and deliver the implant surgically," Redenti said. The new material is more biocompatible, causing less irritation when implanted and no inflammation as the material degrades, he explained. "It can be tolerated by the body's physiology."

The researchers will shortly test the newest implant loaded with the scar-dissolving enzymes and progenitor cells to determine whether the system improves the function of a diseased eye.


Story Source:

The above story is based on materials provided by Case Western Reserve University. Note: Materials may be edited for content and length.


Cite This Page:

Case Western Reserve University. "To restore vision, implant preps and seeds a damaged eye." ScienceDaily. ScienceDaily, 26 January 2010. <www.sciencedaily.com/releases/2010/01/100126153429.htm>.
Case Western Reserve University. (2010, January 26). To restore vision, implant preps and seeds a damaged eye. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2010/01/100126153429.htm
Case Western Reserve University. "To restore vision, implant preps and seeds a damaged eye." ScienceDaily. www.sciencedaily.com/releases/2010/01/100126153429.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins